The evolution of the service marketing literature : 1993-2003

Olivier Furrer,P. Sollberger

Abstract:This article analyzes service research published in marketing journals from 1993 to 2003. Through a content analysis, we study the relationships between service marketing subfields. A MCA allows us to map keywords and authors, and track this literature over the past eleven years. A discussion of the future of service research is also provided.

What problem does this paper attempt to address?

Stretching Effects: High-intensity & Moderate-duration vs. Low-intensity & Long-duration

Sandro R. Freitas,João R. Vaz,Paula M. Bruno,Ricardo J. Andrade,P. Mil‐homens

DOI: https://doi.org/10.1055/s-0035-1548946

2015-12-23

International Journal of Sports Medicine

Abstract:Abstract This study examined whether a high-intensity, moderate-duration bout of stretching would produce the same acute effects as a low-intensity, long-duration bout of stretching. 17 volunteers performed 2 knee-flexor stretching protocols: a high-intensity stretch (i. e., 100% of maximum tolerable passive torque) with a moderate duration (243.5±69.5-s); and a low-intensity stretch (50% of tolerable passive torque) with a long duration (900-s). Passive torque at a given sub-maximal angle, peak passive torque, maximal range of motion (ROM), and muscle activity were assessed before and after each stretching protocol (at intervals of 1, 30 and 60 min). The maximal ROM and tolerable passive torque increased for all time points following the high-intensity stretching (p<0.05), but not after the low-intensity protocol (p>0.05). 1 min post-stretching, the passive torque decreased in both protocols, but to a greater extent in the low-intensity protocol. 30 min post-test, torque returned to baseline for the low-intensity protocol and had increased above the baseline for the high-intensity stretches. The following can be concluded: 1) High-intensity stretching increases the maximal ROM and peak passive torque compared to low-intensity stretching; 2) low-intensity, long-duration stretching is the best way to acutely decrease passive torque; and 3) high-intensity, moderate-duration stretching increases passive torque above the baseline 30 min after stretching.
Clinical Profile, Short-term Prognostic Accuracies of CLIF-C ACLF Score and Serial CLIF-C OF Scores in Acute-on-chronic Liver Failure Patients: A Prospective Observational Study

Gunda J Hareesh,Ramu Ramadoss

DOI: https://doi.org/10.5005/jp-journals-10071-24640

Abstract:Background: Acute-on-chronic liver failure (ACLF) is a recently defined entity that carries high short-term mortality. The European Association for Study of Liver (EASL) has given a different definition for ACLF and derived two scores called Chronic Liver Failure-Consortium Organ Failure (CLIF-C OF) and CLIF-C ACLF to diagnose and predict the short-term outcome, respectively. Materials and methods: This was the prospective observational study, included 40 ACLF patients diagnosed as per the EASL definition and calculated CLIF-C ACLF as well as other scores (CTP, MELD, MELD-Na, CLIF-C OF) on admission. Serial CLIF-C OF scores were also calculated (Day 3 and Day 7). The 28-day and 90-day mortality was recorded. Results: Alcohol was the predominant etiology of cirrhosis (32 patients-80%). Infection was the chief precipitating factor in 19 patients (47.5%). The 28-day and 90-day mortality was 45% and 52.5%. Mean (SD) of CLIF-C ACLF scores of survivors and non-survivors on Day-90 were 44.11(6.62) and 53.86 (7.83). The prognostic accuracy of the CLIF-C ACLF score (Area Under Receiver Operating Characteristic Curve-AUROC) to predict 28-day and 90-day mortality was 0.86 and 0.84, respectively. MELD-Na and CLIF-C ACLF scores had higher AUROC for predicting 28-day and 90-day mortality, respectively. The AUROC of the CLIF-C OF score on Day 3 was found to be higher than the values of Day 1 and Day 7, but it was not statistically significant. Conclusion: CLIF-C ACLF has good short-term prognostic accuracy and it is as good as other available scores. Serial CLIF-C OF scores were equally good in predicting in short-term mortality. How to cite this article: Hareesh GJ, Ramadoss R. Clinical Profile, Short-term Prognostic Accuracies of CLIF-C ACLF Score and Serial CLIF-C OF Scores in Acute-on-chronic Liver Failure Patients: A Prospective Observational Study. Indian J Crit Care Med 2024;28(2):126-133.
Frequency, Clinical Presentation, and Outcome of Acute-on-chronic Liver Failure among Decompensated Cirrhosis of Liver Patients in a Tertiary Care Hospital

Mohammad Golam Azam,Abu Sayeed Mustafa,Md Abu Sayeed Mustafa

DOI: https://doi.org/10.3329/bjm.v34i20.66183

2023-05-24

Bangladesh Journal of Medicine

Abstract:Background: Acute-on-chronic liver failure (ACLF) is characterised by the presence of organ failure in patients with decompensated cirrhosis and is associated with high short-term mortality. Different international entities have taken initiatives to define the condition in different times but recommendations and definitions from The European Association for the Study of the Liver- Chronic Liver Failure (EASL-CLIF) Consortium Acute-on-Chronic Liver Failure in Cirrhosis (CANONIC) study are most comprehensive and widely accepted till date. Only limited data are available on the prevalence, clinical characteristics, and short-term outcomes of ACLF in Bangladesh. It would be very useful for clinicians to identify patients with ACLF early and initiate focused therapy including referral to transplant centers if these data are available. Objective: To evaluate frequency, clinical presentation, and outcome of acute-on-chronic liver failure among decompensated cirrhosis of liver patients. Methods: This prospective observational study was carried out at the Department of Gastrointestinal, Hepatobiliary and Pancreatic Disorders (GHPD), BIRDEM General Hospital, Shahbagh, Dhaka, Bangladesh from July, 2019 to September, 2021. Total 175 patients with decompensated cirrhosis of liver were screened, out of which 22 patients dropped out due to various reasons. Purposive type of non-probability sampling technique was used. Formal ethical clearance was taken from the IRB and ethical measures were ensured in concordance with the Declaration of Helsinki. An informed written consent was taken from all participants. Diagnosis of decompensated cirrhosis was based on clinical, biochemical, radiological and endoscopic findings. Laboratory data sent within 24 hours were collected. Oxygen saturation was measured using fingertip pulse oximeter. Investigations for ACLF triggers were done as necessary which included but not limited to urine routine and microscopic examination, urine culture, blood culture, and Anti HEV IgM. Patients’ prognosis and survivability were observed by follow up phone call at 30 days. All data were recorded in a separate case record form and finally, it was analyzed by SPSS 23. Results: Out of 153 patients, 49 patients (32%) had ACLF: grade 1 ACLF in 26 (17%), grade 2 in 18 (11.8%), and grade 3 in 5 (3.3%) patients. Patients had an average age of 59.54±11.55 years with no significant difference between ACLF and no ACLF groups. Most patients in both groups had others (NAFLD, autoimmune hepatitis, secondary biliary cirrhosis, none) as the main underlying cause of cirrhosis. Bacterial infection, GI bleeding, HEV infection, reactivation of HBV were the precipitating events in 81.6% of patients with ACLF, with bacterial infection being the most common trigger (63.3%). Overall, 44.9% ACLF patients died within 30 days of admission. Older age, male sex, hepatic encephalopathy, GI bleeding, presence of any trigger and higher CTP score were associated with increased risk of death in ACLF. Conclusion: Follow up of 153 patients with decompensated cirrhosis of liver revealed that 1 in 3 patients had ACLF and 44% of them would die in 30 days. Bacterial infection and GI bleeding were the most common triggers of ACLF. Early identification and intervention with multidisciplinary approach and referral to transplant centers are likely to improve survival outcomes in this population. J Medicine 2023; Vol. 34, No. 2(1) Supplement: 221-222
Characteristics and Outcomes of Acute-on-chronic Liver Failure Patients with or Without Cirrhosis Using Two Criteria.

Xiaotian Dong,Jianqin He,Wenyi Chen,Rong Su,Yanping Xu,Xinyu Sheng,Lanjuan Li,Hongcui Cao

DOI: https://doi.org/10.1038/s41598-020-65529-5

IF: 4.6

2020-01-01

Scientific Reports

Abstract:The aim of the study was to identify the characteristics and outcomes in acute-on-chronic liver failure (ACLF) patients with or without cirrhosis using two criteria. Patients with acute deterioration of chronic hepatic disease or acute decompensation of cirrhosis were included retrospectively from April 10, 2016 to April 10, 2019. European Association for the Study of the Liver-chronic liver failure (EASL-CLIF) criterion except for consideration of cirrhosis and Chinese Group on the Study of Severe Hepatitis B (COSSH) criterion were used. Clinical features, laboratory data and survival curves were compared between the ACLF patients with and without cirrhosis. A total of 799 patients were included. Among them, 328 had COSSH and EASL ACLF, 197 had COSSH alone, and 104 had EASL alone. There were 11.6% more ACLF with COSSH criterion. Furthermore, EASL ACLF patients with non-cirrhosis vs. cirrhosis had different laboratory characteristics: ALT (423 vs. 154, p < 0.001), AST (303 vs. 157, p < 0.001), γ-GT (86 vs. 75, p < 0.01), and INR (2.7 vs. 2.6, p < 0.001) were significantly higher but creatinine (71 vs. 77, p < 0.01) were significantly lower; but importantly there was no statistical changes between non-cirrhosis and cirrhosis in EASL ACLF patients on 28-day ( p = 0.398) and 90-day ( p = 0.376) survival curves. However, 90-day ( p = 0.030) survival curve was different between non-cirrhosis and cirrhosis in COSSH ACLF patients. COSSH ACLF score (auROC = 0.778 or 0.792, 95%CI 0.706–0.839 or 0.721–0.851) displayed the better prognostic ability for EASL ACLF patients with non-cirrhosis, but CLIF-C ACLF score (auROC = 0.757 or 0.796, 95%CI 0.701–0.807 or 0.743–0.843) still was the best prognostic scoring system in EASL ACLF patients with cirrhosis. In conclusions, EASL definition exhibited better performance on homogeneous identification of ACLF regardless of cirrhosis or non-cirrhosis. And COSSH ACLF score displayed the better prognostic ability for EASL ACLF patients without cirrhosis.
Outcome Predictors of Acute-on-Chronic Liver Failure: A Narrative Review

Nitish Batra,Shilpa A Gaidhane,Sunil Kumar,Sourya Acharya

DOI: https://doi.org/10.7759/cureus.61655

2024-06-04

Cureus

Abstract:Complications of acute-on-chronic liver failure (ACLF) include increased short-term mortality. Extrahepatic organ failures result from chronic liver disease and acute hepatic injury. This combination characterizes end-stage liver disease. Its rapid progression makes it challenging for hepatologists and intensivists to treat. The varied definitions of this condition lead to varied clinical presentations. Hepatic or extrahepatic failures are more prevalent in chronic hepatitis B or cirrhosis patients who receive an additional injury. Numerous intensity parameters and prognosis ratings, including those for hepatitis B virus (HBV), have been developed and verified for various patients and causes of the disease. Liver regeneration, liver transplantation (LT), or antiviral therapy for HBV-related ACLF are the main treatment aims for various organ failures. LT is the best treatment for HBV-ACLF. In some HBV-related ACLF patients, nucleos(t)ide analogs and artificial liver assistance may enhance survival. Combining epidemiological and clinical studies, this review updates our understanding of HBV-ACLF's definition, diagnosis, epidemiology, etiology, therapy, and prognosis.
Liver Dysfunction and Systemic Inflammation Drive Organ Failures in Acute Decompensation of Cirrhosis: A Multi-Centric Study

Nipun Verma,Akash Roy,Arun Valsan,Pratibha Garg,Samonee Ralmilay,Venkitesh Girish,Parminder Kaur,Sahaj Rathi,Arka De,Madhumita Premkumar,Sunil Taneja,Mahesh Kumar Goenka,Ajay Duseja

DOI: https://doi.org/10.14309/ajg.0000000000003115

2024-10-05

The American Journal of Gastroenterology

Abstract:Introduction: Hospitalized patients with acute decompensation (AD) of cirrhosis are at risk of progressing to acute-on-chronic liver failure (ACLF), significantly increasing their mortality. This study aimed to identify key predictors and patient trajectories predisposing to ACLF. Methods: In this multi-center, prospective study spanning two years, clinical, biochemical, and 90-day survival data were collected from 625 AD patients (EASL criteria) across North, South, and East India. We divided the cohort into a Derivation-cohort (DC: 318 patients) and a Validation-cohort (VC: 307 patients). Predictive models for pre-ACLF were derived, validated, and compared with established scores like MELD3.0 and CLIF-C AD. Results: Of 625 patients, (mean age 49, 83% male, 77.5% with alcohol-related liver disease), 32.2% progressed to ACLF. Patients progressing to ACLF showed significantly higher bilirubin (10.9vs.8.1mg/dl), leukocyte counts (9400vs.8000 per mm 3 ), INR (1.9 vs.1.8), and MELD3.0 (28vs.25), but lower sodium (131vs.134mEq/L) and survival (62% vs.86%) compared to those without progression (p<0.05) in the DC. Consistent results were noted with AH, infection and HE as additional risk factors in VC. Liver failure at presentation [OR: 2.4 (in DC), 6.9 (in VC)] and the seven-day trajectories of bilirubin, INR, and MELD3.0 significantly predicted ACLF progression (p<0.001). A new PRE-ACLF Model showed superior predictive capability (AUC of 0.71 in DC and 0.82 in VC) compared to MELD3.0 and CLIF-C AD scores (p<0.05). Discussion: Approximately one-third of AD patients in this Indian cohort rapidly progressed to ACLF, resulting in high mortality. Early identification of patients at risk can guide targeted interventions to prevent ACLF.

gastroenterology & hepatology
Acute-on-chronic liver failure: far to go—a review

Jinjin Luo,Jiaqi Li,Peng Li,Xi Liang,Hozeifa Mohamed Hassan,Richard Moreau,Jun Li

DOI: https://doi.org/10.1186/s13054-023-04540-4

IF: 15.1

2023-07-04

Critical Care

Abstract:Acute-on-chronic liver failure (ACLF) has been recognized as a severe clinical syndrome based on the acute deterioration of chronic liver disease and is characterized by organ failure and high short-term mortality. Heterogeneous definitions and diagnostic criteria for the clinical condition have been proposed in different geographic regions due to the differences in aetiologies and precipitating events. Several predictive and prognostic scores have been developed and validated to guide clinical management. The specific pathophysiology of ACLF remains uncertain and is mainly associated with an intense systemic inflammatory response and immune-metabolism disorder based on current evidence. For ACLF patients, standardization of the treatment paradigm is required for different disease stages that may provide targeted treatment strategies for individual needs.

critical care medicine
[A case of giant hemangioma of the vertebral canal].

A. Walasik,K. Szopinski

Neurologia i Neurochirurgia Polska

Abstract:An 18-year-old girl with rarely occurring extensive vertebral canal haemangioma is described. The clinical onset of the disease was sudden, with weakness of lower extremities and girdle pains at the level of lower ribs. Despite several recurrences of the symptoms and permanent motor function deficit the patient was able after reparative operations, radiotherapy, rehabilitation treatment and pharmacological therapy to move around unaided using elbow crutches.
Impact of compensated cirrhosis on survival in patients with acute-on-chronic liver failure

Kessarin Thanapirom,Tongluk Teerasarntipan,Sombat Treeprasertsuk,Ashok Choudhury,Manoj K. Sahu,Rakhi Maiwall,Viniyendra Pamecha,Richard Moreau,Mamun Al Mahtab,Yogesh Kumar Chawla,Harshad Devarbhavi,Chen Yu,Qin Ning,Deepak Amarapurkar,Chundamannil E. Eapen,Saeed Sadiq Hamid,Amna Subhan Butt,Dong Joon Kim,Guan H. Lee,Ajit Sood,Laurentious A. Lesmana,Zaigham Abbas,Gamal Shiha,Diana A. Payawal,Man-Fung Yuen,Albert Chan,George Lau,Jidong Jia,Salimur Rahman,Barjesh C. Sharma,Osamu Yokosuka,Shiv Kumar Sarin,Manoj K. Sharma,Sanjiv Saigal,Neeraj Saraf,A. S. Soin,R. K. Dhiman,Ajay Duseja,Sunil Taneja,C. E. Eapen,Ashish Goel,Q. Ning,Tao Chen,Ke Ma,Z. Duan,S. S. Hamid,Amna S. Butt,Wasim Jafri,Akash Shukla,Vivek Saraswat,Soek Siam Tan,Vandana Midha,Omesh Goyal,Hasmik Ghazinyan,Anil Arora,Jinhua Hu,Manoj Sahu,P. N. Rao,Seng G. Lim,Laurentius A. Lesmana,Cosmas Rinaldi Lesmana,Samir Shah,V. G. Mohan Prasad,A. Kadir Dokmeci,Jose D. Sollano,Gian Carpio,Ananta Shresta,G. K. Lau,Md. Fazal Karim,Rino Gani,Kemal Fariz Fariz Kalista,Seema Alam,Rajeev Khanna,Vikrant Sood,Bikrant Bihari Lal,Ankur Jindal,V. Rajan,Vinod Arora,Madunil A. Niriella,Hai Li,Xiaolong Qi,Atsushi Tanaka,Satoshi Mochida,Dominic Ray Chaudhuri,Ed Gane,Khin Maung Win,Wei Ting Chen,Mohd Rela,Dharmesh Kapoor,Amit Rastogi,Pratibha Kale,Archana Rastogi,Chhagan Bihari Sharma,Meenu Bajpai,Virender Singh,Madhumita Premkumar,Sudhir Sudhir,A. Olithselvan,Cyriac Abby Philips,Anshu Srivastava,Surender K. Yachha,Zeeshan Ahmad Wani,B. R. Thapa,Anoop Saraya,Shalimar,Ashish Kumar,Manav Wadhawan,Subash Gupta,Kaushal Madan,Puja Sakhuja,Vivek Vij,Hitendra Garg,Vishal Garg,Chetan Kalal,Lovkesh Anand,Tanmay Vyas,Rajan P. Mathur,Guresh Kumar,Priyanka Jain,Samba Siva Rao Pasupuleti,Yogesh K. Chawla,Abhijit Chowdhury,Shahinul Alam,Do Seon Song,Jin Mo Yang,

DOI: https://doi.org/10.1007/s12072-021-10266-8

IF: 9.029

2021-11-25

Hepatology International

Abstract:Abstract Background and aims Acute-on-chronic liver failure (ACLF) is considered a main prognostic event in patients with chronic liver disease (CLD). We analyzed the 28-day and 90-day mortality in ACLF patients with or without underlying cirrhosis enrolled in the ACLF Research Consortium (AARC) database. Methods A total of 1,621 patients were prospectively enrolled and 637 (39.3%) of these patients had cirrhosis. Baseline characteristics, complications and mortality were compared between patients with and without cirrhosis. Results Alcohol consumption was more common in cirrhosis than non-cirrhosis (66.4% vs. 44.2%, p < 0.0001), while non-alcoholic fatty liver disease/cryptogenic CLD (10.9% vs 5.8%, p < 0.0001) and chronic HBV reactivation (18.8% vs 11.8%, p < 0.0001) were more common in non-cirrhosis. Only 0.8% of patients underwent liver transplantation. Overall, 28-day and 90-day mortality rates were 39.3% and 49.9%, respectively. Patients with cirrhosis had a greater chance of survival compared to those without cirrhosis both at 28-day (HR = 0.48; 95% CI 0.36–0.63, p < 0.0001) and 90-day (HR = 0.56; 95% CI 0.43–0.72, p < 0.0001), respectively. In alcohol CLD, non-cirrhosis patients had a higher 28-day (49.9% vs. 23.6%, p < 0.001) and 90-day (58.4% vs. 35.2%, p < 0.001) mortality rate than cirrhosis patients. ACLF patients with cirrhosis had longer mean survival than non-cirrhosis patients (25.5 vs. 18.8 days at 28-day and 65.2 vs. 41.2 days at 90-day). Exaggerated systemic inflammation might be the reason why non-cirrhosis patients had a poorer prognosis than those with cirrhosis after ACLF had occurred. Conclusions The 28-day and 90-day mortality rates of ACLF patients without cirrhosis were significantly higher than those with cirrhosis in alcoholic CLD. The presence of cirrhosis and its stage should be evaluated at baseline to guide for management. Thai Clinical Trials Registry, TCTR20191226002.

gastroenterology & hepatology
Acute-On-Chronic Liver Failure Defined by Asian Pacific Association for the Study of the Liver Should Include Decompensated Cirrhosis

Manman Xu,Ming Kong,Pengfei Yu,Yingying Cao,Fang Liu,Bing Zhu,Yizhi Zhang,Wang Lu,Huaibin Zou,Shaoli You,Shaojie Xin,Zhongping Duan,Tao Han,Yu Chen

DOI: https://doi.org/10.3389/fmed.2021.750061

IF: 3.9

2021-10-15

Frontiers in Medicine

Abstract:Background and Aims: Acute-on-chronic liver failure (ACLF) is an acute deterioration of chronic liver disease with high short-term mortality. The inclusion or exclusion of previously decompensated cirrhosis (DC) in the diagnostic criteria of ACLF defined by the Asian Pacific Association for the Study of the Liver (APASL-ACLF) has not been conclusive. We aimed to evaluate the prognostic impact of decompensated cirrhosis in ACLF. Methods: We retrospectively collected a cohort of patients with a diagnosis of APASL-ACLF (with or without DC) hospitalized from 2012 to 2020 at three liver units in tertiary hospitals. Baseline characteristics and survival data at 28, 90, 180, 360, 540, and 720 days were collected. Results: Of the patients assessed using APASL-ACLF criteria without the diagnostic indicator of chronic liver disease, 689 patients were diagnosed with ACLF, of whom 435 had no decompensated cirrhosis (non-DC-ACLF) and 254 had previously decompensated cirrhosis (DC-ACLF). The 28-, 90-, 180-, 360-, 540-, and 720-day mortality were 24.8, 42.9, 48.7, 57.3, 63.4, and 68.1%, respectively, in DC-ACLF patients, which were significantly higher than in non-DC-ACLF patients ( p < 0.05). DC was independently associated with long-term (180/360/540/720 days) but not short-term (28/90 days) mortality in patients with ACLF. Age, total bilirubin, international normalized ratio, and hepatic encephalopathy were independent risk factors for short- and long-term mortality risk in ACLF patients ( p < 0.05). Conclusions: Patients with DC-ACLF have a higher mortality rate, especially long-term mortality, compared to non-DC-ACLF patients. Therefore, DC should be included in the diagnostic criteria of APASL-ACLF and treated according to the ACLF management process.

medicine, general & internal
Acute-on-chronic liver failure in severe acute alcoholic hepatitis: impact on management, prognostication, and urgency of liver transplantation

G. Perricone,C. Mazzarelli,R. Viganò,P. Prandoni,M. Vangeli,F. Aprile,M. Cucco,C. Becchetti,R. Stigiliano,L. Cesarini,A. Airoldi,M. Scaravaglio,G. Monti,A. Lauterio,L.S. Belli

DOI: https://doi.org/10.1016/j.dld.2024.01.061

IF: 5.165

2024-02-01

Digestive and Liver Disease

Abstract:Introduction A better identification of factors predicting the course, outcome, and need for urgent liver transplantation in patients with severe acute alcoholic hepatitis (SAAH) is needed. Acute-on-chronic liver failure (ACLF) can occur in SAAH, and its impact on management, prognostication, and need for urgent liver transplantation in SAAH should be clarified. Aim To describe the impact of ACLF on management, prognostication, and need for urgent liver transplantation in SAAH. Materials and Methods Patients with SAAH referred to our center between April 2016 and May 2023, with those non-responders to medical treatment (MT) being evaluated for LT. Results One hundred patients were included, with a median Maddrey Discriminant Function of 72 and a median MELD-Na score of 28. At presentation, 52 patients had ACLF grade 0-1, and 48 ACLF grade 2-3 (31 grade 2, 17 grade 3) (see Figure 1). In the latter group, circulatory failure was present in 3 (6.25%), and respiratory failure in 4 (8.3%). SAAH was the only precipitant factor in 50 (96%) and 36 (75%) patients with ACLF grade 0-1 and ACLF grade 2-3, respectively, with infection being an associated factor in 1 (2%) and 8 (17%), and GI bleeding in 1 (2%) and 5 (10%), respectively. Non-response to MT was significantly higher in patients with ACLF grade 2-3 (39/48, 81%) than in those with ACLF grade 0-1 (14/52, 27%). ACLF grade 2-3 was associated with a corresponding higher need of early LT (ACLF grade 2-3: 14/48, 29% vs ACLF grade 0-1: 3/52, 5.7%; p = 0.004). ACLF status at presentation (ACLF grade 2-3 vs ACLF grade 0-1) resulted a better predictor of outcome (death or LT) than MELD-Na (>= or <30) (4.42 [2.67; 7.33] vs 2.50 [1.51; 4.12]). Conclusions ACLF is a frequent presentation of SAAH. Severe ACLF predicts non-response to MT, indicating the urgency of liver transplantation.

gastroenterology & hepatology
Bacterial Infection and Predictors of Mortality in Patients with Autoimmune Liver Disease-Associated Acute-On-Chronic Liver Failure

Xuan Zhang,Ping Chen,Hainv Gao,Shaorui Hao,Meifang Yang,Hong Zhao,Jianhua Hu,Weihang Ma,Lanjuan Li

DOI: https://doi.org/10.1155/2018/5108781

2018-01-01

Canadian Journal of Gastroenterology and Hepatology

Abstract:Objective To date, few studies are available on autoimmune liver disease-associated acute-on-chronic liver failure (ACLF). The aim of this study is to investigate bacterial infection and predictors of mortality in these patients. Methods We retrospectively studied patients with autoimmune liver disease from August 2012 to August 2017. Clinical data of the patients were retrieved for analysis. Results There were 53 ACLF patients and 53 patients without ACLF in this study. The ACLF group had a higher prevalence of complications (P < 0.05). The 28-day and 90-day mortality rates were also obviously high in patients with ACLF (38.3% and 74.5%, resp.) (P < 0.05). No predictor was significantly associated with 28-day and 90-day transplant-free mortality. In 53ACLF patients, 40 (75.5%) patients showed bacterial infection. ACLF patients with bacterial infection showed high Child-Pugh score, MELD score, CLIF-SOFA score, 28-day mortality, and 90-day mortality (P > 0.05). Moreover, C-reactive protein (CRP) using 12.15 mg/L cut-off value proved to be more accurate than procalcitonin in identifying patients with infection. Conclusions Autoimmune liver disease-associated ACLF showed more complications and high mortality. Bacterial infection patients displayed a more severe condition than those without infection. Elevated CRP is an accurate marker for diagnosing bacterial infection in autoimmune liver disease-associated ACLF patients.
An investigative report on the phenomenon of postponing the birth of a second child among farmers in Liaoning province.

J. Cao,Q. Zhang,Z. Wang,F. Liu,Z. Kang

Abstract: This study examines the patterns of postponement of a second birth among couples in Liaoning Province in China. By 1995, 3.849 million couples out of a possible 5.394 million couples of childbearing age accepted the One-Child Certificate. 77,000 couples gave up the quota that granted permission to have a second child, of whom 5200 had an only daughter. 23,000 couples who accepted the quota allowing a second child did not have a second child. Second child postponement behavior includes couples accepting a quota and not bearing a child and couples not accepting a quota. Analysis of data from a minority sample area in three townships in Caohe Cheng Man Nationality Autonomous Township of Benxi Man Nationality Autonomous County reveals that 1863 couples postponed a second birth. 53.07% of postponing couples had a junior high school level of education. 41.73% had a primary school education. 52.39% of wives had a primary school education, and 44.54% had a junior high school education. 61.60% of husbands had a junior high school education, and 31.06% had a primary school education. Postponing couples ranged in annual per capita income from 20,000 to 330 yuan. Ganjingzi District had the highest average household income per capita. More economically developed areas had smaller gaps between the highest and lowest income levels. The gap in Ganjingzi District of Dalian City was 5340 yuan. The gap in underdeveloped Benxi County was 15,000 yuan. More economically developed areas also had higher levels of education of wives. The longest duration of birth postponement was 8 years; the average was 4 years. 48.82% of couples made joint decisions regarding postponement. 73.05% of couples postponed due to the desire for economic benefits and a nonmaterialistic life. 20 different reasons were reported by couples. Birth heaping is a direct problem due to postponement.
Comparing CLIF-C ACLF, CLIF-C ACLFlactate, and CLIF-C ACLF-D Prognostic Scores in Acute-on-Chronic Liver Failure Patients by a Single-Center ICU Experience

Chao-Cheng Kuo,Chien-Hao Huang,Ching Chang,Pin-Cheng Chen,Bo-Huan Chen,Wei-Ting Chen,Yu-Pin Ho

DOI: https://doi.org/10.3390/jpm11020079

IF: 3.5083

2021-01-29

Journal of Personalized Medicine

Abstract:Patients with liver cirrhosis have a higher risk of developing acute-on-chronic liver failure (ACLF). Poor prognosis with a high rate of short-term mortality leads to limited opportunities for further liver transplantation. Thus, precise prognostic evaluation of patients with ACLF is necessary before transplant surgery. In this study, a total of one hundred and thirty-five patients with ACLF admitted to the hepato-gastroenterologic intensive care unit (ICU) for intensive monitoring and treatment at Chang-Gung Memorial Hospital (CGMH, Linkou, Taiwan) were screened from November 2012 to April 2015 and tracked until April 2017. Three new prognostic scores of ACLF, including CLIF-C ACLF (Chronic Liver Failure Consortium Acute-on-chronic Liver Failure score), CLIF-C ACLF-D (CLIF-C ACLF Development score), and CLLF-C ACLFlactate (lactate-adjusted CLIF-C ACLF score) were compared. The primary outcome considered was overall mortality. Mortality predictions at 28, 90, 180, and 365 days were also calculated. By area under the receiver operating characteristic curve (AUROC) analysis, the CLIF-C ACLF and CLIF-C ACLF-D scores were superior to CLIF-C ACLFlactate scores in predicting 28-day mortality. The CLIF-C ACLF-D score had the highest AUROC in predicting overall mortality as well as at 90, 180, and 365 days. In conclusion, our study demonstrates that CLIF-C ACLF and CLIF-C ACLF-D scores are significant predictors of outcome in critical patients with liver cirrhosis and ACLF. The CLIF-C ACLF-D score may have a superior predictive power for the prediction of 3-month, 6-month, and one-year mortality.

medicine, general & internal,health care sciences & services
Mechanisms and treatment approaches for ACLF

Salvatore Piano,Nadim Mahmud,Paolo Caraceni,Marta Tonon,Rajeshwar Prosad Mookerjee

DOI: https://doi.org/10.1111/liv.15733

2023-09-16

Abstract:Acute-on-chronic liver failure (ACLF) is a life-threatening syndrome characterized by decompensation of cirrhosis, severe systemic inflammation and organ failures. ACLF is frequently triggered by intra- and/or extrahepatic insults, such as bacterial infections, alcohol-related hepatitis or flares of hepatic viruses. The imbalance between systemic inflammation and immune tolerance causes organ failures through the following mechanisms: (i) direct damage of immune cells/mediators; (ii) worsening of circulatory dysfunction resulting in organ hypoperfusion and (iii) metabolic alterations with prioritization of energetic substrates for inflammation and peripheral organ 'energetic crisis'. Currently, the management of ACLF includes the support of organ failures, the identification and treatment of precipitating factors and expedited assessment for liver transplantation (LT). Early LT should be considered in patients with ACLF grade 3, who are unlikely to recover with the available treatments and have a mortality rate > 70% at 28 days. However, the selection of transplant candidates and their prioritization on the LT waiting list need standardization. Future challenges in the ACLF field include a better understanding of pathophysiological mechanisms leading to inflammation and organ failures, the development of specific treatments for the disease and personalized treatment approaches. Herein, we reviewed the current knowledge and future perspectives on mechanisms and treatment of ACLF.
Increased Delayed Mortality in Patients with Acute‐on‐chronic Liver Failure Who Have Prior Decompensation

Yu Shi,Ming-hua Zheng,Ying Yang,Wu Wei,Qiao Yang,Airong Hu,Yaoren Hu,Yihua Wu,Huadong Yan

DOI: https://doi.org/10.1111/jgh.12787

2014-01-01

Journal of Gastroenterology and Hepatology

Abstract:Background and AimPatients with acute-on-chronic liver failure (ACLF) represent a complex population with differential prognosis. The aim of the study was to categorize ACLF according to the severity of underlying chronic liver diseases.MethodsA total of 540 ACLF patients were recruited, including 127 with prior decompensated cirrhosis and 413 without prior decompensation (PD) including 193 with underlying chronic hepatitis and 220 with prior compensated cirrhosis. The clinical characteristics and prognosis of subgroups were compared. Cox proportional hazard model and multinominal logistic regression analysis were performed to identify significant prognostic parameters.ResultsThe 28-day, 3-month and 1-year survival of ACLF patients with or without PD were 58.9% versus 61.4%, 36.2 versus 52.5%, and 29.1% versus 49.6%, respectively. On multinominal logistic regression analysis or time-to-death analysis by Cox proportional hazard model, PD was significantly associated with post-28-day mortality but not within-28-day mortality. On multivariate time-to-death analysis, older age, high international normalized ratio (INR) and serum bilirubin, low levels of serum sodium and platelet count, and presence of hepatic encephalopathy (HE), upper gastrointestinal bleeding, and respiratory or circulation dysfunction were predictors of within-28-day mortality in patients without PD, whereas the risk factors in patients with PD were high INR, creatinine, presence of HE, and respiratory or circulation dysfunction.ConclusionACLF patients with or without PD had comparable short-term prognosis but differential 1-year mortality. ACLF patients with PD were distinct from those without PD in age, types of acute insults, severity of hepatic damage, and distribution of complications, and the former group was characterized by increased delayed mortality.
A Modified Meld Model For Chinese Pre-Aclf And Aclf Patients And It Reveals Poor Prognosis In Pre-Aclf Patients

Qi Xia,Xiahong Dai,Yimin Zhang,Yongzheng Guo,Xiaowei Xu,Qian Yang,Weibo Du,Xiaoli Liu,Yuemei Chen,Jianrong Huang,Lanjuan Li

DOI: https://doi.org/10.1371/journal.pone.0064379

IF: 3.7

2013-01-01

PLoS ONE

Abstract:Background & Aims: Acute-on-chronic liver failure (ACLF) is one of the most deadly, prevalent, and costly diseases in Asia. However, no prognostic model has been developed that is based specifically on data gathered from Asian patients with ACLF. The aim of the present study was to quantify the survival time of ACLF among Asians and to develop a prognostic model to estimate the probability of death related to ACLF.Methods: We conducted a retrospective observational cohort study to analyze clinical data from 857 patients with ACLF/ pre-ACLF who did not undergo liver transplantation. Kaplan-Meier and Cox proportional hazards regression model were used to estimate survival rates and survival affected factors. The area under the receiver operating characteristic curve (auROC) was used to evaluate the performance of the models for predicting early mortality.Results: The mortality rates among patients with pre-ACLF at 12 weeks and 24 weeks after diagnosis were 30.5% and 33.2%, respectively. The mortality rates among patients with early-stage ACLF at 12 weeks and 24 weeks after diagnosis were 33.9% and 37.1%, respectively. The difference in survival between pre-ACLF patients and patients in the early stage of ACLF was not statistically significant. The prognostic model identified 5 independent factors significantly associated with survival among patients with ACLF and pre-ACLF: the model for end-stage liver disease (MELD) score; age, hepatic encephalopathy; triglyceride level and platelet count.Conclusion: The findings of the present study suggest that the Chinese diagnostic criteria of ACLF might be broadened, thus enabling implementation of a novel model to predict ACLF-related death after comprehensive medical treatment.
Risk of different precipitating events for progressing to acute-on-chronic liver failure in HBV-related cirrhotic patients.

Shan Yin,Shi Jin Wang,Wen Yi Gu,Yan Zhang,Liu Ying Chen,Hai Li

DOI: https://doi.org/10.1111/1751-2980.12480

2017-01-01

Journal of Digestive Diseases

Abstract:OBJECTIVEAcute-on-chronic liver failure (ACLF) is a distinct syndrome that develops in patients with cirrhosis and acute decompensation (AD). This study focused on the precipitating events (PEs) of hepatitis B virus (HBV)-related cirrhotic patients diagnosed as ACLF based on the Chronic Liver Failure Consortium organ failure (CLIF-C OF) score. METHODSHospitalized patients with HBV-related cirrhosis and AD were retrospectively included. The patients' characteristics, laboratory test results, PEs, CLIF-C OF score and short-term prognosis were evaluated. RESULTSOf the 890 patients enrolled 300 (33.7%) were diagnosed as ACLF and 590 (66.3%) without ACLF. ACLF patients had a higher incidence of PEs than those without ACLF. The ACLF patients were more prone to having PEs of bacterial infection (P<0.001), HBV reactivation (P<0.001), active alcoholism (P=0.036) and superimposed hepatitis virus infection (P=0.031), whereas portal vein thrombosis (P=0.002) were less common in the non-ACLF group. ACLF patients with the top four single PEs had diverse types of organ failures. However, they shared a similar short-term prognosis. While in patients without PEs the ACLF group had higher systemic inflammation and deterirated outcomes compared with the non-ACLF group. CONCLUSIONS PEs of bacterial infection, HBV reactivation, active alcoholism and superimposed hepatitis virus infection, but not GI hemorrhage or portal vein thrombosis, were risk factors for ACLF. There may be two types of patients with ACLF based on the differences in the clinical manifestation of the disease.
Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update

Shiv Kumar Sarin,Ashok Choudhury,Manoj K Sharma,Rakhi Maiwall,Mamun Al Mahtab,Salimur Rahman,Sanjiv Saigal,Neeraj Saraf,A S Soin,Harshad Devarbhavi,Dong Joon Kim,R K Dhiman,Ajay Duseja,Sunil Taneja,C E Eapen,Ashish Goel,Q Ning,Tao Chen,Ke Ma,Z Duan,Chen Yu,Sombat Treeprasertsuk,S S Hamid,Amna S Butt,Wasim Jafri,Akash Shukla,Vivek Saraswat,Soek Siam Tan,Ajit Sood,Vandana Midha,Omesh Goyal,Hasmik Ghazinyan,Anil Arora,Jinhua Hu,Manoj Sahu,P N Rao,Guan H Lee,Seng G Lim,Laurentius A Lesmana,Cosmas Rinaldi Lesmana,Samir Shah,V G Mohan Prasad,Diana A Payawal,Zaigham Abbas,A Kadir Dokmeci,Jose D Sollano,Gian Carpio,Ananta Shresta,G K Lau,Md Fazal Karim,Gamal Shiha,Rino Gani,Kemal Fariz Kalista,Man-Fung Yuen,Seema Alam,Rajeev Khanna,Vikrant Sood,Bikrant Bihari Lal,Viniyendra Pamecha,Ankur Jindal,V Rajan,Vinod Arora,Osamu Yokosuka,Madunil A Niriella,Hai Li,Xiaolong Qi,Atsushi Tanaka,Satoshi Mochida,Dominic Ray Chaudhuri,Ed Gane,Khin Maung Win,Wei Ting Chen,Mohd Rela,Dharmesh Kapoor,Amit Rastogi,Pratibha Kale,Archana Rastogi,Chhagan Bihari Sharma,Meenu Bajpai,Virender Singh,Madhumita Premkumar,Sudhir Maharashi,A Olithselvan,Cyriac Abby Philips,Anshu Srivastava,Surender K Yachha,Zeeshan Ahmad Wani,B R Thapa,Anoop Saraya,Shalimar,Ashish Kumar,Manav Wadhawan,Subash Gupta,Kaushal Madan,Puja Sakhuja,Vivek Vij,Barjesh C Sharma,Hitendra Garg,Vishal Garg,Chetan Kalal,Lovkesh Anand,Tanmay Vyas,Rajan P Mathur,Guresh Kumar,Priyanka Jain,Samba Siva Rao Pasupuleti,Yogesh K Chawla,Abhijit Chowdhury,Shahinul Alam,Do Seon Song,Jin Mo Yang,Eileen L Yoon,APASL ACLF Research Consortium (AARC) for APASL ACLF working Party.

DOI: https://doi.org/10.1007/s12072-019-09946-3

Abstract:The first consensus report of the working party of the Asian Pacific Association for the Study of the Liver (APASL) set up in 2004 on acute-on-chronic liver failure (ACLF) was published in 2009. With international groups volunteering to join, the "APASL ACLF Research Consortium (AARC)" was formed in 2012, which continued to collect prospective ACLF patient data. Based on the prospective data analysis of nearly 1400 patients, the AARC consensus was published in 2014. In the past nearly four-and-a-half years, the AARC database has been enriched to about 5200 cases by major hepatology centers across Asia. The data published during the interim period were carefully analyzed and areas of contention and new developments in the field of ACLF were prioritized in a systematic manner. The AARC database was also approached for answering some of the issues where published data were limited, such as liver failure grading, its impact on the 'Golden Therapeutic Window', extrahepatic organ dysfunction and failure, development of sepsis, distinctive features of acute decompensation from ACLF and pediatric ACLF and the issues were analyzed. These initiatives concluded in a two-day meeting in October 2018 at New Delhi with finalization of the new AARC consensus. Only those statements, which were based on evidence using the Grade System and were unanimously recommended, were accepted. Finalized statements were again circulated to all the experts and subsequently presented at the AARC investigators meeting at the AASLD in November 2018. The suggestions from the experts were used to revise and finalize the consensus. After detailed deliberations and data analysis, the original definition of ACLF was found to withstand the test of time and be able to identify a homogenous group of patients presenting with liver failure. New management options including the algorithms for the management of coagulation disorders, renal replacement therapy, sepsis, variceal bleed, antivirals and criteria for liver transplantation for ACLF patients were proposed. The final consensus statements along with the relevant background information and areas requiring future studies are presented here.
Risk Factors for Invasive Pulmonary Aspergillosis and Hospital Mortality in Acute-On-Chronic Liver Failure Patients: A Retrospective-Cohort Study

Jiajia Chen,Qing Yang,Jianrong Huang,Lanjuan Li

DOI: https://doi.org/10.7150/ijms.6824

2013-01-01

International Journal of Medical Sciences

Abstract:Background: Invasive pulmonary aspergillosis (IPA) in acute-on-chronic liver failure (ACLF) patients is associated with a high mortality. But the clinical characteristics of and the risk factors for IPA among patients with ACLF remains unclear. This study was aimed at assessing clinical manifestation, the risk factors and antifungal medications for as well as the mortality due to IPA in ACLF patients at the First Affiliated Hospital, College of Medicine, Zhejiang University. Patients and Methods: Patients with ACLF who were diagnosed with proven or probable IPA by clinical and laboratory parameters from 1 December 2008 to 1 May 2012 were retrospectively evaluated to determine the risk factors for IPA and the clinical outcomes. The follow-up ended on 30 July 2012. Multivariate analysis was performed to identify the risk factors for mortality and the development of IPA. Results: In total, 787 patients with ACLF were enrolled, and 39 of these patients developed IPA. Thirty seven of these 39 patients died in spite of treatment with antifungal drugs. Controls included 48 patients who did not have a pulmonary infection. The survival rate of patients with IPA was significantly lower than that of those without IPA. IPA was found to be independently associated with age (p = 0.021), encephalopathy (p = 0.002), and steroid use (p = 0.000). There was significant difference in the prognosis between the patients treated with either voriconazole or itraconazole and those without antifungal treatment. Conclusions: Patients with ACLF and IPA have a high mortality rate. Patients with ACLF who present with encephalopathy should avoid steroids, as they increase the mortality rate. Azoles may prolong the survival time.

The evolution of the service marketing literature : 1993-2003

Stretching Effects: High-intensity & Moderate-duration vs. Low-intensity & Long-duration

Clinical Profile, Short-term Prognostic Accuracies of CLIF-C ACLF Score and Serial CLIF-C OF Scores in Acute-on-chronic Liver Failure Patients: A Prospective Observational Study

Frequency, Clinical Presentation, and Outcome of Acute-on-chronic Liver Failure among Decompensated Cirrhosis of Liver Patients in a Tertiary Care Hospital

Characteristics and Outcomes of Acute-on-chronic Liver Failure Patients with or Without Cirrhosis Using Two Criteria.

Outcome Predictors of Acute-on-Chronic Liver Failure: A Narrative Review

Liver Dysfunction and Systemic Inflammation Drive Organ Failures in Acute Decompensation of Cirrhosis: A Multi-Centric Study

Acute-on-chronic liver failure: far to go—a review

[A case of giant hemangioma of the vertebral canal].

Impact of compensated cirrhosis on survival in patients with acute-on-chronic liver failure

Acute-On-Chronic Liver Failure Defined by Asian Pacific Association for the Study of the Liver Should Include Decompensated Cirrhosis

Acute-on-chronic liver failure in severe acute alcoholic hepatitis: impact on management, prognostication, and urgency of liver transplantation

Bacterial Infection and Predictors of Mortality in Patients with Autoimmune Liver Disease-Associated Acute-On-Chronic Liver Failure

An investigative report on the phenomenon of postponing the birth of a second child among farmers in Liaoning province.

Comparing CLIF-C ACLF, CLIF-C ACLFlactate, and CLIF-C ACLF-D Prognostic Scores in Acute-on-Chronic Liver Failure Patients by a Single-Center ICU Experience

Mechanisms and treatment approaches for ACLF

Increased Delayed Mortality in Patients with Acute‐on‐chronic Liver Failure Who Have Prior Decompensation

A Modified Meld Model For Chinese Pre-Aclf And Aclf Patients And It Reveals Poor Prognosis In Pre-Aclf Patients

Risk of different precipitating events for progressing to acute-on-chronic liver failure in HBV-related cirrhotic patients.

Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update

Risk Factors for Invasive Pulmonary Aspergillosis and Hospital Mortality in Acute-On-Chronic Liver Failure Patients: A Retrospective-Cohort Study